June 2014
Reactions Weekly;Jun2014, Vol. 1506 Issue 1, p19
An abstract of the article "Sustained increase of serum creatine phosphokinase levels and progressive muscle abnormalities associated with raltegravir use during 32-week follow-up in an HIV-1 experienced patient on simplified HAART regimen, intolerant to protease inhibitors and abacavir: a case report," by O. Cirioni and colleagues is presented.


Related Articles

  • Creatine kinase elevation in HIV-1-infected patients receiving raltegravir-containing antiretroviral therapy: a cohort study. Monteiro, Polyana; Perez, Iñaki; Pich, Judit; Gatell, Jose Maria; Martínez, Esteban // Journal of Antimicrobial Chemotherapy (JAC);Feb2013, Vol. 68 Issue 2, p404 

    Objectives To evaluate the incidence and risk factors for significant creatine kinase elevation in HIV-1-infected patients who were prescribed a raltegravir-containing antiretroviral therapy. Design A retrospective analysis of a prospectively collected cohort involving all consecutive patients...

  • Darunavir/efavirenz/raltegravir.  // Reactions Weekly;8/6/2011, Issue 1363, p16 

    The article describes the case of a 42-year-old man with HIV-1 infection who developed raltegravir resistance in his cerebrospinal fluid after receiving a raltegravir-containing antiretroviral regime.

  • Raltegravir.  // Reactions Weekly;1/8/2011, Issue 1333, p32 

    This article describes a case study of a 56-year-old woman with HIV-1 infection who developed cerebellar ataxia during treatment with raltegravir.

  • Calcium/colecalciferol/raltegravir interaction.  // Reactions Weekly;12/3/2011, Issue 1380, p11 

    The article describes the case of a 39-year-old HIV-positive man who developed decreased raltegravir concentrations while receiving raltegravir and calcium/colecalciferol.

  • Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: results from a multicenter study. Madeddu, G.; Soddu, V.; Ricci, E.; Quirino, T.; Menzaghi, B.; Bellacosa, C.; Grosso, C.; Melzi, S.; Valsecchi, L.; Franzetti, M.; Vichi, F.; Penco, G.; Di Biagio, A.; Pellicanò, G.; Corsico, L.; De Socio, G. V. L.; Mazzotta, E.; Parruti, G.; Guastavigna, M.; Orofino, G. // Journal of the International AIDS Society;2010 Supplement 4, Vol. 13 Issue Suppl 4, p1 

    An abstract of the research paper "Muscle Symptoms and Creatine Phosphokinase Elevations in Patients Receiving Raltegravir in Clinical Practice: Results From a Multicenter Study," by G. Madeddu and colleagues which was presented at the Tenth International Congress on Drug Therapy in HIV...

  • Daptomycin.  // Reactions Weekly;May2015, Vol. 1553 Issue 1, p113 

    The article presents case studies of six patients aged 37-85 years who experienced elevated levels of creatine phosphokinase (CPK) after the administration of daptomycin.

  • CNS SYMPTOMS COMMON IN PEOPLE TAKING RALTEGRAVIR. Carter, Michael // HIV Australia;2012, Vol. 10 Issue 2, p50 

    The article reports on a study which reveals that approximately 10% of patients taking antiretroviral drug, raltegravir (Isentress) develope central nervous system (CNS) side-effects.

  • Atazanavir/raltegravir.  // Reactions Weekly;Oct2015, Vol. 1572 Issue 1, p34 

    The article presents case studies of two patients who developed integrase inhibitor resistance during treatment with atazanavir and raltegravir.

  • Risperidone.  // Reactions Weekly;5/1/2004, Issue 999, p13 

    Discuses research being done on the development of elevated serum creatine kinase levels in a teenage boy while receiving risperidone for catatonic schizophrenia. Reference to a study by M. Meyer et al published in a November 2003 issue of "Pharmacopsychiatry"; Drug dosage administered to the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics